Skip to main content
SpringerLink
Log in

Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension

  • Research Letter
  • Published:
Journal of Human Hypertension Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. WHO–ISH Hypertension Guidelines Committee. 1999 World Health Organization – International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–185.

  2. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755–1762.

    Article  CAS  Google Scholar 

  3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.

    Article  CAS  Google Scholar 

  4. 2003 European Society of Hypertension. European Society of Cardiology guidelines for management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.

  5. Burnier M, Brunner HR . Angiotensin II receptor antagonists. Lancet 2000; 355: 637–645.

    Article  CAS  Google Scholar 

  6. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611–616.

    Article  CAS  Google Scholar 

  7. Cook NR, Cohen J, Hekbert PR, Taylor JO, Hennekens CH . Implication of small reductions in diastolic blood pressure for primary prevention. Arch Int Med 1995; 155: 701–709.

    Article  CAS  Google Scholar 

  8. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D . Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 1999; 100: 354–360.

    Article  CAS  Google Scholar 

  9. Staessen JA, Wang JG, Thijs L . Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305–1315.

    Article  CAS  Google Scholar 

  10. Asmar R, Lacourciere Y . A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. J Hypertens 2000; 18: 1683–1690.

    Article  CAS  Google Scholar 

  11. Neutel JM . Clinical studies of CS-866, the newest angiotensin II receptor antagonist. Am J Cardiol 2001; 87: 37C–43C.

    Article  CAS  Google Scholar 

  12. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022–2031.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum der Ruhr-Universität Bochum, Marienhospital Herne, Bochum, Germany

    L C Rump

  2. Division of Internal Medicine, St Orsola Hospital University of Bologna, Bologna, Italy

    E Ambrosioni

  3. Service de Néphrologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

    M Burnier

  4. Innere Medizin III/AKH, Wien, Austria

    W Hörl

  5. Leiden University Medical Center, Leiden, The Netherlands

    A J Rabelink

Authors
  1. L C Rump
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Ambrosioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Burnier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W Hörl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rump, L., Ambrosioni, E., Burnier, M. et al. Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension. J Hum Hypertens 20, 299–301 (2006). https://doi.org/10.1038/sj.jhh.1001984

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001984

  • Springer Nature Limited

This article is cited by

Search

Navigation